Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gastroparesis
Biotech
Vanda receives FDA rejection, issues fiery response
The biotech came out swinging after the blow, accusing the FDA of sending a complete response letter that generally disregarded the evidence.
Nick Paul Taylor
Sep 19, 2024 8:02am
Neurogastrx bags $60M to join crowded gastrointestinal field
Aug 26, 2021 6:30am
Neurogastrx reels in $45M series A for gastroparesis med
Jan 5, 2018 11:11am
UPDATED: Allergan pays $200M+ for GI candidate on PhIIb data
Oct 27, 2016 9:49am
Single-asset biotech Altos gains Takeda R&D backing
Jul 1, 2016 8:57am
